Compass Therapeutics Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Compass Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on oncology and antibody-based therapeutics. Its work centers on the relationship between angiogenesis, the immune system, and tumor growth, with a pipeline designed to engage multiple biological pathways needed for an effective anti-tumor response. The company aims to modulate the tumor microvasculature, activate immune effector cells within the tumor microenvironment, and counteract immunosuppressive mechanisms used by tumors to evade immune surveillance. Founded in 2014, Compass operates as a mid-sized organization within the biotechnology research sector, developing candidates for standalone use or in combination with its own pipeline antibodies. In late 2025, Compass announced it would present at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026. The company plans to advance its product candidates through clinical development as standalone therapies or in combination with its own pipeline antibodies, based on supportive clinical and nonclinical data.
1-888-653-2347 
support@leadiq.com 
